https://www.selleckchem.com/pr....oducts/tolebrutinib-
In vivo direct drug targeting aims at delivering drug molecules loaded on microrobots to the diseased site using the shortest possible physiological routes, which potentially improves targeting efficiency and reduces systemic toxicity. It is thus essential to consider realistic in-body limitations for direct drug targeting applications. Here, we present a novel controller for microrobot maneuver by considering four key in vivo constraints non-Euclidean structure of capillaries, irreversibility of blood flow, invisibility
إعجاب
علق
شارك
